BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2342056)

  • 1. Structure-activity relationships of the lissoclinamides: cytotoxic cyclic peptides from the ascidian Lissoclinum patella.
    Hawkins CJ; Lavin MF; Marshall KA; van den Brenk AL; Watters DJ
    J Med Chem; 1990 Jun; 33(6):1634-8. PubMed ID: 2342056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella.
    Degnan BM; Hawkins CJ; Lavin MF; McCaffrey EJ; Parry DL; van den Brenk AL; Watters DJ
    J Med Chem; 1989 Jun; 32(6):1349-54. PubMed ID: 2724305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cytotoxic compounds from the ascidian Lissoclinum bistratum.
    Degnan BM; Hawkins CJ; Lavin MF; McCaffrey EJ; Parry DL; Watters DJ
    J Med Chem; 1989 Jun; 32(6):1354-9. PubMed ID: 2724306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patellamide F, A new cytotoxic cyclic peptide from the colonial ascidian Lissoclinum patella.
    Rashid MA; Gustafson KR; Cardellina JH; Boyd MR
    J Nat Prod; 1995 Apr; 58(4):594-7. PubMed ID: 7623037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patellamide E: a new cyclic peptide from the ascidian Lissoclinum patella.
    McDonald LA; Ireland CM
    J Nat Prod; 1992 Mar; 55(3):376-9. PubMed ID: 1593285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular conformation of patellamide A, a cytotoxic cyclic peptide from the ascidian Lissoclinum patella, by X-ray crystal analysis.
    In Y; Doi M; Inoue M; Ishida T; Hamada Y; Shioiri T
    Chem Pharm Bull (Tokyo); 1993 Oct; 41(10):1686-90. PubMed ID: 8281568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization studies of ioactive cyclic peptides in the ascidian Lissoclinum patella.
    Salomon CE; Faulkner DJ
    J Nat Prod; 2002 May; 65(5):689-92. PubMed ID: 12027743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bistratamides M and N, Oxazole-Thiazole Containing Cyclic Hexapeptides Isolated from Lissoclinum bistratum Interaction of Zinc (II) with Bistratamide K.
    Urda C; Fernández R; Rodríguez J; Pérez M; Jiménez C; Cuevas C
    Mar Drugs; 2017 Jul; 15(7):. PubMed ID: 28671564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bistratamides E-J, modified cyclic hexapeptides from the Philippines ascidian Lissoclinum bistratum.
    Perez LJ; Faulkner DJ
    J Nat Prod; 2003 Feb; 66(2):247-50. PubMed ID: 12608858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cyclic peptides from the ascidian Lissoclinum patella.
    Fu X; Do T; Schmitz FJ; Andrusevich V; Engel MH
    J Nat Prod; 1998 Dec; 61(12):1547-51. PubMed ID: 9868162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamandarins A and B: new cytotoxic depsipeptides from a Brazilian ascidian of the family Didemnidae.
    Vervoort H; Fenical W; Epifanio RA
    J Org Chem; 2000 Feb; 65(3):782-92. PubMed ID: 10814011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patellamide A, a cytotoxic cyclic peptide from the ascidian Lissoclinum patella.
    In Y; Doi M; Inoue M; Ishida T; Hamada Y; Shioiri T
    Acta Crystallogr C; 1994 Mar; 50 ( Pt 3)():432-4. PubMed ID: 8018309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of the antitumor candidate trunkamide A by 2D NMR and restrained simulated annealing methods.
    Salvatella X; Caba JM; Albericio F; Giralt E
    J Org Chem; 2003 Jan; 68(2):211-5. PubMed ID: 12530842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of ulithiacyclamide B. Antitumor evaluation of cyclic peptides and macrolides from Lissoclinum patella.
    Williams DE; Moore RE; Paul VJ
    J Nat Prod; 1989; 52(4):732-9. PubMed ID: 2809606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient biomimetic total synthesis and structural verification of bistratamides E and J from Lissoclinum bistratum.
    You SL; Kelly JW
    Chemistry; 2004 Jan; 10(1):71-5. PubMed ID: 14695551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of libraries of thiazole, oxazole and imidazole-based cyclic peptides from azole-based amino acids. A new synthetic approach to bistratamides and didmolamides.
    Bertram A; Maulucci N; New OM; Mohd Nor SM; Pattenden G
    Org Biomol Chem; 2007 May; 5(10):1541-53. PubMed ID: 17571182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of mononuclear and chloro-bridged binuclear copper(II) complexes of patellamide D, a naturally occurring cyclic peptide: influence of anion and solvent.
    van den Brenk AL; Tyndall JD; Cusack RM; Jones A; Fairlie DP; Gahan LR; Hanson GR
    J Inorg Biochem; 2004 Nov; 98(11):1857-66. PubMed ID: 15522413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic labdane alkaloids from an ascidian Lissoclinum sp.: isolation, structure elucidation, and structure-activity relationship.
    Uddin J; Ueda K; Siwu ER; Kita M; Uemura D
    Bioorg Med Chem; 2006 Oct; 14(20):6954-61. PubMed ID: 16854586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascidiacyclamides containing oxazoline and thiazole motifs assume square conformations and show high cytotoxicity.
    Asano A; Yamada T; Taniguchi T; Sasaki M; Yoza K; Doi M
    J Pept Sci; 2018 Oct; 24(10):e3120. PubMed ID: 30221432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Didmolamide A and B, two new cyclic hexapeptides from the marine ascidian Didemnum molle.
    Rudi A; Chill L; Aknin M; Kashman Y
    J Nat Prod; 2003 Apr; 66(4):575-7. PubMed ID: 12713422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.